BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Prostate
,
Holistic medicine
,
Trichostatin A
,
rs4950928
,
FABP1
,
Obesity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
MGL 3
Summary
General Info
Curated Studies
Most Correlated Studies
Toxicogenomic responses of C. elegans to gold nanoparticles
Explore Curated Studies Results
Literature
Most Relevant Literature
Metabotropic Glutamate Receptor 4 (mGlu4) Positive Allosteric Modulators Lack Efficacy in Rat and Ma…
Dissociation of impulsive traits by subthalamic metabotropic glutamate receptor 4.
Activation of metabotropic glutamate receptor 4 regulates proliferation and neural differentiation i…
Putative mGluR4 positive allosteric modulators activate Gi-independent anti-inflammatory mechanisms …
Discovery and characterization of a novel series of N-phenylsulfonyl-1H-pyrrole picolinamides as pos…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH a…
A Phase 3 Study to Evaluate the Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatt…
Drug Interaction Study of MGL-3196 With Atorvastatin
A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alco…
Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ